CRNX - Crinetics Pharmaceuticals appoints Garlan Adams as general counsel

Crinetics Pharmaceuticals (CRNX) announces the appointment of Garlan Adams to the newly created role of general counsel.Adams brings to Crinetics more than two decades of experience managing legal and compliance matters associated with the development and commercialization of innovative pharmaceutical and biotechnology products.She was previously an advisor to Indivior on a broad spectrum of complex compliance and litigation matters related to product commercialization including patient access, among others.

For further details see:

Crinetics Pharmaceuticals appoints Garlan Adams as general counsel